CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
DSX
Diana Shipping Inc.
There isn't enough reported data to score DSX yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
DSX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Weak |
DSX's profitability is currently strong, but its balance sheet is weak. There isn't enough data to rate its revenue and cash flow.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
DSX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.1x | $1.48 | -39% |
| Forward | 4.2x | $2.43 | — |
| Current | 5.1x | $2.43 | — |
| Fair | 9.5x | $4.56 | +88% |
| Expensive | 29x | $13.88 | +471% |
Historical ranges are pointers, not guarantees.
DSX has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
DSX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for DSX, with profitability improving.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
DSX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.59 | +22% |
| Q2 2026 | $0.48 | +300% |
| Q4 2025 | $0.11 | +120% |
| Q2 2025 | $0.12 | +33% |
| Q4 2024 | $0.05 | -88% |
| Q2 2024 | $0.09 | -90% |
| Q4 2023 | $0.42 | -69% |
| Q2 2023 | $0.93 | -31% |
| Q4 2022 | $1.36 | +127% |
DSX has the edge over CAT in the latest year-over-year earnings comparison.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over DSX in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
DSX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $112M | +2.2% |
| Q4 2025 | $103.9M | -9.3% |
| Q2 2025 | $109.6M | -3.5% |
| Q4 2024 | $114.6M | -6.2% |
| Q2 2024 | $113.6M | -19% |
| Q4 2023 | $122.1M | -18% |
| Q2 2023 | $140M | -0.3% |
| Q4 2022 | $149.5M | +19% |
DSX's revenue has slid since its 2018 peak: $112M last quarter, down 1.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 21% | -3.4 points |
| Q4 2025 | 17% | -10 points |
| Q2 2025 | 22% | -15 points |
| Q4 2024 | 27% | -20 points |
| Q2 2024 | 24% | -27 points |
| Q4 2023 | 28% | -14 points |
| Q2 2023 | 37% | +25 points |
| Q4 2022 | 48% | +114 points |
DSX has the edge over CAT on profitability, with a higher operating margin.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
DSX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $36M | +44% |
| Q4 2025 | $20.9M | -38% |
| Q2 2025 | $25M | -46% |
| Q4 2024 | $33.4M | +94% |
| Q2 2024 | $46.4M | +98% |
| Q4 2023 | $17.2M | +$146.8M |
| Q2 2023 | $23.4M | -60% |
| Q4 2022 | -$129.5M | -384% |
DSX's free cash flow has turned positive again: $115M over the past year, against −$42M the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over DSX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
DSX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.8% | +3.1M shares |
| 1 year | +0.7% | +766K shares |
| 3 years | +19% | +18.4M shares |
| 5 years | +40% | +32.5M shares |
DSX has 114M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q4 2025 | — |
| Q2 2025 | $23M |
| Q4 2023 | — |
| Q2 2023 | — |
| Q4 2022 | $2.9M |
| Q2 2022 | $928,000 |
| Q4 2021 | $30.2M |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over DSX on leverage, with a lower net debt burden relative to earnings.
DSX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 5.0x | High |
| Q4 2025 | 5.3x | High |
| Q2 2025 | 4.2x | High |
| Q4 2024 | 3.8x | Elevated |
| Q2 2024 | 3.6x | Elevated |
| Q4 2023 | 3.0x | Elevated |
| Q2 2023 | 2.4x | Moderate |
| Q4 2022 | 2.4x | Moderate |
DSX's net debt is about 5.0 years of its operating earnings (EBITDA), up from 3.6 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
DSX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.0 | Neutral |
| Stochastic | 18.5 | Oversold |
DSX's weekly RSI is 47 (neutral) and its Stochastic is 18 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
DSX PE vs Industrials Sector
| Metric | DSX | Sector median | Relative |
|---|---|---|---|
| PE | 5.1x | 24x | 79% below |
| PE % | 32 | 58 | 26 pts below |
DSX has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
DSX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.60 | 6.5% below |
| 20 week MA | $2.56 | 5.1% below |
| 50 week MA | $2.39 | 1.7% above |
| 100 week MA | $2.03 | 20% above |
| 200 week MA | $2.61 | 6.9% below |
DSX's trend is mixed: it's above two of its five weekly moving averages, and 6.9% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
DSX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.08 | $1.90 | -38% |
| 2021 | $1.90 | $3.94 | +107% |
| 2022 | $3.94 | $3.99 | +1.3% |
| 2023 | $3.99 | $2.97 | -26% |
| 2024 | $2.97 | $1.87 | -37% |
| 2025 | $1.87 | $1.70 | -9.1% |
| 2026 YTD | $1.70 | $2.43 | +43% |
DSX has the edge over CAT on returns for 2026, with the stronger performance.